Citazione APA

Kelley, R. K., Ryoo, B., Merle, P., Park, J., Bolondi, L., Chan, S. L., . . . Abou-Alfa, G. K. (2020). Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: A subgroup analysis of the phase 3 CELESTIAL trial. ESMO Open.

Stile di citazione Chicago

Kelley, Robin Kate, et al. "Second-line Cabozantinib After Sorafenib Treatment for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the Phase 3 CELESTIAL Trial." ESMO Open 2020.

Citazione MLA

Kelley, Robin Kate, et al. "Second-line Cabozantinib After Sorafenib Treatment for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the Phase 3 CELESTIAL Trial." ESMO Open 2020.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.